It is hence paramount to control for placebo effects in modern brain therapies to avoid false hopes.The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, researchers said in background notes.The treatment involves placing electrodes on the foreheads of children with ADHD while they sleep.The battery-powered electrodes stimulate the trigeminal nerve, targeting a branch of the facial nerve thought to activate the brainstem and, from there, other brain regions linked to ADHD, researchers said.The FDAs approval came following a small U.S
This has expanded the pool of available prescribers for telehealth platforms and improved access statewide
We know that the supplement industry can be confusing, with conflicting information and flashy marketing
Hyperuricemia and coronary heart disease: The mediating role of blood pressure and thrombospondin 3
Stevens makes the case for retail politics On a summer afternoon in South Haven, a community along Lake Michigan, Stevens walks into a pet supply store with the ease of a seasoned campaigner
Never discontinue prescribed medication without medical guidance